Population pharmacokinetics of caffeine in neonates and young infants

Therapeutic Drug Monitoring

Volumn 18, Issue 3, 1996, Pages 245-253

  Thomson, A H ^b,c   Kerr, S ^a   Wright, S ^a  

^a NHS LOTHIAN   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Caffeine; Infants; Neonates; Pharmacokinetics; Population

Indexed keywords

CAFFEINE CITRATE;

ARTICLE; BODY WEIGHT; DOSE RESPONSE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG MONITORING; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXAMETHASONE; DRUG INTERACTIONS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; POPULATION; REFERENCE VALUES;

EID: 0029951494     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199606000-00005     Document Type: Article

References (16)

1. Anwar M, Mondestin H, Mojica N, et al. Effect of caffeine on pneumogram and apnoea of infancy. Arch Dix Child 1986;61:891-5.
2. Kao L, Durand DJ, Phillips BL, Nickerson BG. Oral theophylline and diuretics improve pulmonary mechanics in infants with bronchopulmonary dysplasia. J Pediatr 1987;11:439-44.
3. Hams MC, Baumgart S, Rooklin AR, Fox WW. Successful extubation of infants with respiratory distress syndrome using aminophylline. J Pediatr 1983;103:303-5.
4. Moore ES, Faix RG, Banagale RC, Grasela TH. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm 1989;17:47-66.
5. Giacoia GP, Jungbluth GL, Jusko WJ. Effects of formula feeding on oral absorption of caffeine in premature infants. Dev Pharmacol Ther 1989;12:205-10.
6. Aranda JV, Cook CE, Gorman W, et al. Pharmacokinetic profile of caffeine in the premature newborn infant with apnoea. J Pediatr 1979;94:663-8.
7. Scanlon JEM, Chin KC, Morgan MEI, Durbin GM, Hale KA, Brown SS. Caffeine or theophylline tor neonatal apnoea. Arch Dis Child 1992;67:425-8.
8. Gorodischer R, Karplus M. Pharmacokinetic aspects of caffeine in premature infants with apnoea. Eur J Clin Pharmacol 1982;22:47-52.
9. Le Guennec J-C, Billon B, Pare C. Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease and breast-feeding. Pediatrics 1985;76:834-40.
10. Sheiner LB, Rosenberg R, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 1977;5: 445-79.
11. NONMEM users guide. San Francisco: NONMEM Project Group, University of California, 1992.
12. Thomson AH, Way S, Bryson SM, McGovern EM, Kelman AW, Whiting B. Population pharmacokinetics of gentamicin in neonates. Dev Pharmacol Ther 1988;11:173-9.
13. Fattinger K, Vozeh S, Olafsson A, Vlcek J, Wenk M, Follath F. Netilmicin in the neonate: population pharmacokinetic analysis and dosing recommendations. Clin Pharmacol Ther 1991;50:55-65.
14. Karlsson MO, Thomson AH, McGovern EM, Chow P, Evans TJ, Kelman AW. Population pharmacokinetics of rectal theophylline in neonates. Ther Drug Monit 1991;13:195-200.
15. Buchanan N, Hurwitz S, Butler P. Asthma - a possible interaction between hydrocortisone and theophylline. S Afr Med J 1979;56:1147-8.
16. Leavengood DC, Bunker-Soler AL, Nelson HS. The effect of corticosteroids on theophylline metabolism. Ann Allergy 1983;50:249-51.